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IMMUNODIAGNOSIS OF HUMAN STRONGYLOIDIASIS: USE OF SIX DIFFERENT ANTIGENIC 
FRACTIONS FROM Strongyloides venezuelensis PARASITIC FEMALES
Marcelo Andreetta CORRAL(1,2), Fabiana Martins de PAULA(1,2), Maiara GOTTARDI(1,2), Dirce Mary Correia Lima MEISEL(1,2), Vera Lucia Pagliusi CASTILHO(3), 
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SUMMARY
The aim of this study was to evaluate six different antigenic fractions from Strongyloides venezuelensis parasitic females for the 
immunodiagnosis of human strongyloidiasis. Soluble and membrane fractions from S. venezuelensis parasitic females were prepared 
in phosphate-buffered saline (SSF and SMF, respectively), Tris-HCl (TSF and TMF, respectively), and an alkaline buffer (ASF and 
AMF, respectively). Serum samples obtained from patients with strongyloidiasis or, other parasitic diseases, and healthy individuals 
were analyzed by enzyme-linked immunosorbent assay (ELISA). Soluble fractions SSF, TSF, and ASF showed 85.0%, 75.0%, and 
80.0% sensitivity and 93.1%, 93.1%, and 87.5% specificity, respectively. Membrane fractions SMF, TMF, and AMF showed 80.0%, 
75.0%, and 85.0% sensitivity, and 95.8%, 90.3%, and 91.7% specificity, respectively. In conclusion, the present results suggest 
that the fractions obtained from parasitic females, especially the SSF and SMF, could be used as alternative antigen sources in the 
serodiagnosis of human strongyloidiasis.
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Human strongyloidiasis is often caused by the nematode 
Strongyloides stercoralis. This parasite is found worldwide but is mainly 
located in tropical and subtropical regions17. In humans, S. stercoralis 
can cause an asymptomatic chronic gastrointestinal infection. However, 
in immunocompromised individuals this parasite can cause a fatal 
hyperinfection syndrome or disseminated strongyloidiasis14.
A definitive diagnosis of strongyloidiasis is made through the 
detection of larvae in feces; however, parasitological methods have low 
sensitivity because of the irregular and intermittent release of larvae 
into feces10. Immunological methods have been widely used in the 
diagnosis of human strongyloidiasis because of their high sensitivity3. 
A major limitation of these methods is that it can be difficult to obtain 
sufficient quantities of S. stercoralis larvae for fractionation and analysis. 
If alternative antigens were available, including those from heterologous 
species such as Strongyloides venezuelensis, more satisfactory results for 
the immunodiagnosis of human strongyloidiasis might be possible2,4,7.
Antigenic preparations from S. venezuelensis filariform larvae are 
most often used in the standardization and application of immunological 
techniques4,7. Considering the life cycle of Strongyloides spp., it is 
necessary to study other antigenic sources, such as female parasites, 
as they are found in the intestinal mucosa of the host and might elicit 
an immune response5,6. The aim of our study was to evaluate different 
antigenic fractions from S. venezuelensis parasitic females for their 
application in the immunodiagnosis of human strongyloidiasis.
Antigenic fractions from S. venezuelensis parasitic females were 
evaluated by samples of immunocompetent individuals. Serum samples 
were obtained from individuals at the Hospital das Clínicas of the 
Faculdade de Medicina at the Universidade de São Paulo (HCFMUSP). 
Of these, 20 patients were harboring S. stercoralis larvae. Thirty-two 
patients were infected with other parasites: hookworm (n = 4); Ascaris 
lumbricoides (n = 2); Blastocystis spp. (n = 3); Enterobius vermicularis 
(n = 1); Endolimax nana (n = 3); Giardia intestinalis (n = 3); Hymenolepis 
nana (n = 1); Schistosoma mansoni (n = 9); hookworm and H. nana 
(n = 1); S. mansoni, A. lumbricoides, Entamoeba coli, Blastocystis spp., 
and E. nana (n = 1); G. intestinalis and E. nana (n = 1); A. lumbricoides 
and Blastocystis spp (n = 1); E. nana, S. mansoni, and Blastocystis spp 
(n = 1); hookworm, Escherichia coli, Entamoeba dispar/histolytica, 
and Schistosoma mansoni (n = 1). The remaining 40 samples were 
from seemingly healthy volunteers based on their clinical observation, 
without evidence of contact with S. stercoralis or previous history of 
strongyloidiasis, and negative in all parasitological diagnostic methods. 
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For each group, one stool sample was analyzed by the techniques 
described by LUTZ12 and RUGAI et al.19 and an agar plate culture 
method18. The study received approval (protocol 266.046) from the 
Research Ethics Committee of the Universidade de São Paulo (Sao 
Paulo, Brazil). 
S. venezuelensis parasitic females were obtained from Wistar rats 
(Rattus norvegicus) that were experimentally infected using protocol 
CPE-IMT 2011/126. To recover parasitic females, rats were euthanized 
on day 14 post-infection. The small intestines were then removed as 
described by NAKAI & AMARANTE15. Briefly, the intestine was 
longitudinally sectioned and placed on a sedimentation chalice in contact 
with saline solution for four h at 37 ºC; the females were then counted 
and stored at -20 ºC until use.
For antigenic extraction, approximately 5,000 parasitic females 
(F) were incubated with three different extraction buffers: 10 mM 
phosphate-buffered saline (PBS, pH 7.2), 25 mM Tris-HCl (pH 7.5), 
or 0.15 M NaOH. All the extraction buffers were supplemented with 
protease inhibitors (Sigma-Aldrich, St. Louis, MO, USA). Each 
extraction buffer was used to generate soluble (S) and membrane (M) 
antigenic fractions. For the soluble fractions, parasitic females were 
added to PBS (S), Tris-HCl (T), or NaOH (A) and disrupted in an ice 
bath using a tissue homogenizer. The suspensions were centrifuged at 
12,400 × g for 30 min at 4 ºC and supernatants collected. The soluble 
fractions in PBS, Tris-HCl, and NaOH were designated SSF, TSF, and 
ASF, respectively. For membrane fractions, SSF and ASF pellets were 
resuspended in 1% sodium dodecyl sulfate (SDS), boiled for five min 
at 100 ºC, and centrifuged (12,400 × g, 30 min, 4 ºC); subsequently, the 
supernatants were collected. These membrane fractions were designated 
SMF and AMF. The TSF pellets were resuspended in 7 M urea, 2 M 
thiourea, and 2% CHAPS ([(3-cholamidopropyl) dimethyl-ammonio]-1-
propanesulfonate); then, they were disrupted in an ice bath using a tissue 
homogenizer. The samples were centrifuged (12,400 × g, 30 min, 4 ºC) 
and supernatants were collected; these fractions were designated TMF. 
All fractions were analyzed for protein content according to the method of 
LOWRY et al.11, subdivided into aliquots, and stored at -20 ºC until use. 
Fractions were subjected to sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) as described by LAEMMLI9 under reducing 
conditions. Each of the antigenic fractions (SSF, TSF, ASF, SMF, TMF, 
and AMF) was electrophoresed using a 12% acrylamide separation gel. 
The gels were then analyzed using PlusOne Coomassie table PhastGel 
Blue R-350 (GE HealthCare Bio-Sciences AB, Piscataway, NJ, USA).
Enzyme-linked immunosorbent assays (ELISAs) were performed 
according to CORRAL et al.2, with some modifications. Briefly, the wells 
of polystyrene microplates (Corning-Costar, New York, NY, USA) were 
coated with SSF, TSF, ASF, SMF, TMF, or AMF (5 μg/mL) in carbonate-
bicarbonate buffer (0.06 mM, pH 9.6) and incubated overnight at 4 °C. 
After incubation, plates were washed (3 × 5 min) with PBS containing 
0.05% (v/v) Tween 20 (PBS-T), and blocked with PBS-T supplemented 
with 3% (w/v) nonfat milk (PBS-TM) for 45 min at 37 °C. Serum samples 
were diluted 1:400 and 1:200 in PBS-TM for the soluble and membrane 
fractions, respectively. Fc-specific goat anti-human IgG conjugated to 
peroxidase (Sigma-Aldrich, St. Louis, MO, USA) was diluted 1:30,000 
in PBS-TM. Color was developed by adding enzyme substrate (4 mM 
orthophenylenediamine, 0.03% H2O2, 0.1 M citrate phosphate buffer, 
pH 5.5) and incubated at room temperature for 15 min in the dark. The 
reactions were stopped by adding 2 N H2SO4. The optical density (OD) 
was determined at 492 nm using an ELISA reader (Thermo Fischer 
Scientific, Waltham, MA, USA). 
Statistical analyses were performed using GraphPad Prism version 
5.0 (Graph Pad Software Inc. San Diego, USA). The ELISA index (EI) 
was calculated according to the following formula: EI = OD/cutoff. An EI 
value greater than one for a sample was considered positive. Tests were 
evaluated by calculating sensitivity, specificity, accuracy, kappa index 
(k), and likelihood ratio (LR). Any p-value below 0.05 was considered 
statistically significant.
To our knowledge, the present study is the first to use different 
antigenic fractions from S. venezuelensis parasitic females for the 
immunodiagnosis of human strongyloidiasis. We used six antigenic 
fractions from parasitic females; three fractions were soluble and three 
were membrane-derived. The concentration of proteins from SSF, TSF, 
and ASF were 0.174, 0.174 and 0.708 mg/mL, respectively. Membrane 
fractions showed protein concentration of 0.631 (SMF), 0.300 (TMF), 
and 0.261 mg/mL (AMF). Although differences were observed in protein 
concentration, there was no change in the pattern of electrophoretic 
migration for the six fractions investigated, presenting bands of 25 and 
150 kDa, and almost all samples presenting a band of approximately 
23 kDa (Fig. 1). 
The diagnostic parameters and efficiency of ELISA for the six 
antigenic fractions are shown in Fig. 2. Among the soluble fractions, 
SSF had the highest value of sensitivity and specificity (85% and 93.1%, 
respectively). The value of sensitivity and specificity for the membrane 
fraction SMF were also high, at 80% and 95.8%, respectively. The k 
values ranged from 0.619 to 0.753 for the soluble fractions, and 0.630 
to 0.772 for the membrane fractions. Of the six fractions tested, those 
obtained using PBS provided optimal diagnostic parameters. An LR 
Fig. 1 - Electrophoretic profiles of soluble (SSF, TSF, and ASF) and membrane (SMF, 
TMF, and AMF) fractions from Strongyloides venezuelensis parasitic females, obtained 
using 12% SDS-PAGE and Coomassie blue staining. MW, molecular weight standard in 
kilodaltons (kDa).
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greater than 10 indicates high performance with respect to the detection 
of specific IgG antibodies in patients with strongyloidiasis7. In this study, 
the antigenic fractions obtained with PBS had high LRs (12.2-19.2), 
indicating that these preparations had high ability to discriminate between 
strongyloidiasis patients and controls.
Differences among values for diagnosis were observed; it may be due 
to changes in the action of buffers used for the production of antigenic 
fractions, which can facilitate the antigen-antibody interaction. In general, 
there are major concerns regarding the antigenic preparations used in 
serological tests, especially regarding the evaluation of buffers used for 
the extraction of proteins, which is fundamental to obtaining antigens4. 
Cross-reactivity was observed for the six antigenic fractions with the 
following parasites: hookworms (1/4 in SSF and TMF), Schistosoma 
mansoni (2/9 in TSF and TMF), A. lumbricoides (1/2 in ASF), G. 
intestinalis (1/3 in AMF), Blastocystis spp (1/3 in ASF), and poly-
infection with hookworms and H. nana (1/1 in SSF, ASF, and AMF).
The various forms of the S. venezuelensis filarial larvae during the 
parasite life cycle can be easily obtained in murine models13. The use 
of parasitic females has not been widely explored, possibly because 
of the difficulties involved in obtaining sufficient numbers for antigen 
production. However, specific proteins are present in parasitic females, 
and these proteins present new possibilities for antigen production16. 
Recently, GONÇALVES et al.5,6 showed that antigens from S. 
venezuelensis parasitic females could be used in the immunodiagnosis 
of human strongyloidiasis.
This study is the first to report the use of membrane antigens from S. 
venezuelensis parasites females. Our results showed high specificity of the 
membrane antigens compared with those in soluble preparations. The use 
of membrane fractions from S. venezuelensis infective larvae has shown 
promising results for the immunodiagnosis of human strongyloidiasis2. 
It is difficult to obtain specific antigenic fractions for the immune 
diagnosis of strongyloidiasis, and a reliable diagnostic test is urgently 
required. To produce antigens for the diagnosis of human strongyloidiasis, 
the use of heterologous species maintained in experimental models has 
been proposed. Therefore, female parasites represent a viable antigenic 
source; however, its use as a source of antigens remains uncommon. 
GONÇALVES et al.5,6, who used an alkaline extract similar to ASF from 
S. venezuelensis parasitic females, reported similar results with respect 
to sensitivity and specificity as seen in the present study. Other antigenic 
fractions from the female parasite were not investigated by these authors. 
In our current study, we have shown that different antigenic extracts from 
female parasites can be used in the diagnosis of human strongyloidiasis.
The increasing use of recombinant antigens for the serological 
diagnosis of human strongyloidiasis has shown some promise1,8. However, 
there are some limitations regarding resources in areas that are endemic 
for this helminthiasis. This lack of resources makes the application of 
these methodologies problematic in most regions. If a laboratory has 
adequate infrastructure and reagents for the production of recombinant 
antigens, then this technique could be viable. Nevertheless, in countries 
where the conditions are limited, the antigenic extracts preparations 
should be based on protocol, lower cost, and with good sensitivity and 
specificity results. Thus, the use of S. venezuelensis parasitic females, 
especially soluble and membrane fractions extracted with PBS, could 
provide an alternative source of antigens for the immunodiagnosis of 
human strongyloidiasis.
RESUMO
Imunodiagnóstico da estrongiloidíase humana: o uso de seis 
diferentes frações antigênicas de fêmeas parasitas de Strongyloides 
venezuelensis
O objetivo deste estudo foi avaliar seis frações antigênicas diferentes 
de fêmeas parasitas de Strongyloides venezuelensis para o diagnóstico 
sorológico da estrongiloidíase humana. As frações solúveis e de 
membrana de fêmeas parasitas de S. venezuelensis foram preparadas em 
solução salina tamponada (SSF e SMF, respectivamente), Tris-HCl (TSF e 
TMF, respectivamente) e tampão alcalino (ASF e AMF, respectivamente). 
As amostras de soro obtidas de pacientes com estrongiloidíase, com 
outras parasitoses e indivíduos saudáveis, foram analisadas pelo ensaio 
imunoenzimático (ELISA). As frações solúveis SSF, TSF e ASF 
Fig. 2 - ROC curve indicating the optimum point of reaction (cut-off), sensitivity (Se), specificity (Sp), diagnostic efficiency (DE), kappa index (k), likelihood ratio (LR), and area under curve 
(AUC) for IgG detection in serum samples using soluble (SSF, TSF, and ASF) and membrane (SMF, TMF, and AMF) fractions from Strongyloides venezuelensis parasitic females.
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apresentaram sensibilidade de 85,0%, 75,0%, e 80,0% e especificidade 
de 93,1%, 93,1% e 87,5%, respectivamente. As frações de membrana, 
SMF, TMF e AMF demonstraram sensibilidade de 80,0%, 75,0%, e 
85,0%, e especificidade de 95,8%, 90,3% e 91,7%, respectivamente. 
Em conclusão os presentes resultados sugerem que as frações obtidas 
a partir de fêmeas parasitas, especialmente o SSF e SMF, podem ser 
utilizadas como fonte alternativa de antígenos no imunodiagnóstico da 
estrongiloidiase humana.
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